Steven Kutalek, MD
Clinical Cardiac Electrophysiology · Langhorne, PANPI 1730137258
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Philips North America LLC at 29.0% of the total. Reporting peaked in 2021 at $41,080 and has fallen 61.2% since, to $15,938 in 2025. Among clinical cardiac electrophysiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $505.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$51K
- Boston Scientific$42K
- Bardy Diagnostics, Inc.$39K
- Baxter Healthcare$36K
- Abbott$4K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- plus $3K from 27 others
Across 41 payments — averaging $2450.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$59K
- Microport CRM USA Inc$25K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
- Abbott$7K
- Biotronik Inc.$553
What the payments were for
- Consulting fees$96,75255%
- Speaking & faculty fees$54,21631%
- Travel & lodging$15,9589%
- Food & beverage$10,3666%
- Education$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 63 | $51,407 |
| Boston Scientific | 95 | $42,056 |
| Bardy Diagnostics, Inc. | 33 | $38,840 |
| Baxter Healthcare | 30 | $36,209 |
| Abbott | 17 | $4,265 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $1,667 |
| Medtronic | 8 | $488 |
| Microport CRM USA Inc | 7 | $256 |
| Biotronik Inc. | 4 | $215 |
| Pfizer | 13 | $215 |
| Impulse Dynamics (USA) Inc. | 4 | $199 |
| E.r. Squibb & Sons, L.L.C. | 12 | $176 |
| Sanofi-aventis U.S. LLC | 9 | $167 |
| Atricure, Inc. | 5 | $153 |
| Kestra Medical Technology Services, Inc. | 2 | $124 |
| Biosense Webster, Inc. | 7 | $121 |
| Stryker | 1 | $119 |
| Novartis | 6 | $116 |
| Cook Medical LLC | 1 | $101 |
| Altathera Pharmaceuticals LLC | 4 | $82 |
| Johnson & Johnson | 4 | $78 |
| Boehringer Ingelheim | 3 | $42 |
| Medicomp Inc | 2 | $32 |
| Cardiva Medical, Inc. | 1 | $28 |
| AstraZeneca | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Watermark Medical, Inc. | 1 | $22 |
| Merck | 1 | $22 |
| Amgen | 1 | $18 |
| GSK | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carnation Ambulatory Monitor$38,336
- Hillrom - Carnation Ambulatory Monitor$36,000
- (9520) IGT Devices Undivided$28,278
- GENERAL - THERAPIES$27,760
- Bridge$14,709
- CLINICAL TRIAL PRODUCT$5,125
- Quartet CRT Lead$3,675
- QC$2,500
- (9124) LM Undivided$1,547
- LifeVest$1,500
- TightRail$1,497
- IGT Devices Und$918
- Spectranetics Undiv$433
- GlideLight$265
- Spartacus$136
- LUX-DX$134
- Lasers$132
- IGT D Therapy$132
- AURORA EV-ICD MRI SURESCAN$132
- Ensite Cardiac Mapping System$127
How this compares
$177,333 in reported general payments places this provider in the 90th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $26,291 |
| XareltoRivaroxaban | 14 | $14,967 |
| MultaqDronedarone Hcl | 11 | $14,544 |
| Dofetilide | 23 | $4,131 |
| Pindolol | 19 | $1,677 |
| Flecainide Acetate | 45 | $1,296 |
| Metoprolol Succinate | 38 | $738 |
| Propafenone Hcl | 11 | $382 |
| Diltiazem Hcl | 24 | $276 |
| Losartan Potassium | 13 | $206 |
| Atorvastatin Calcium | 19 | $197 |
| Carvedilol | 17 | $121 |
| Amlodipine Besylate | 19 | $104 |
| Cephalexin | 20 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $215 | $26,29123 claims |
| Johnson & JohnsonXarelto | $78 | $14,96714 claims |
| Sanofi-aventis U.S. LLCMultaq | $167 | $14,54411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Langhorne
- Karim NathanLanghorne$42K
- Seth WorleyLancaster$3.7M
- John ChenaridesPittsburgh$750K
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pugazhendhi VijayaramanWilkes Barre$594K
- Pasquale SantangeliPhiladelphia$581K
- Joshua SilversteinPittsburgh$557K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.